Low-molecular-weight heparin in the management of Trousseau's syndrome.

Background: Thrombophlebitis migrans is a major cause of morbidity in approximately 11% of patients with cancer. Thrombosis may predate the appearance of malignancy, and patients with thrombosis often respond poorly to warfarin.

Methods: Four patients with extensive thrombosis and cancer are described in this article.